Pharmaceutical-grade CBD producer shows commitment to increasing white label format capabilities Industry leader, Vantage Hemp Co. (“Vantage” or the “Company”), announces softgel capabilities in response to meeting client and consumer demands. As the Company expands its white label and contract manufacturing services,...
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.
The demand for cannabidiol (CBD) is growing fast in the pharmaceutical sector, thanks to increased awareness among consumers about CBD health benefits.
Vantage is a global leader in the production of CBD extracts with its facilities achieving ICH Q7 and WHO Good Manufacturing Practices (GMP) certification.